Abbott Hit With Permanent Injunction
The judge overseeing a patent suit between Abbott Laboratories Inc. and Innogenetics NV over hepatitis C genotyping technology has issued a permanent injunction prohibiting Abbott from selling or using products that...To view the full article, register now.
Already a subscriber? Click here to view full article